Literature DB >> 10219018

Prognostic impact of cyclin-dependent kinase inhibitor p27kip1 in node-positive breast cancer.

A Tsuchiya1, G J Zhang, M Kanno.   

Abstract

BACKGROUND AND OBJECTIVES: p27kip1 (p27) plays an important role as a negative regulator of cell cycle-dependent kinase activity during progression of the cell cycle. The most important prognosticator of breast cancer is nodal status, and the aim of this study was to determine the prognostic implication of p27 in breast cancer patients with lymph node metastases.
METHODS: Immunohistochemical staining for p27 was performed on tissues from 102 patients with node-positive breast cancer.
RESULTS: A nuclear staining over 50% was defined as high expression. High expression of p27 was shown in 59 patients (57.8%). A significant correlation was found between high p27 and positive estrogen receptor status, but there was no correlation between p27 staining and age, menopausal status, nodal status, or tumor size. Low expression of p27 was significantly associated with shorter survival. A multivariate analysis also showed that the only independent variable was p27.
CONCLUSIONS: The results indicated that low expression of p27 was an independent factor associated with poor prognosis. Therefore, p27 can be an important tool in making therapeutic decisions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10219018     DOI: 10.1002/(sici)1096-9098(199904)70:4<230::aid-jso6>3.0.co;2-i

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  12 in total

1.  p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy.

Authors:  Peggy L Porter; William E Barlow; I-Tien Yeh; Ming Gang Lin; Xiaopu P Yuan; Elizabeth Donato; George W Sledge; Charles L Shapiro; James N Ingle; Charles M Haskell; Kathy S Albain; James M Roberts; Robert B Livingston; Daniel F Hayes
Journal:  J Natl Cancer Inst       Date:  2006-12-06       Impact factor: 13.506

Review 2.  p27 deregulation in breast cancer: prognostic significance and implications for therapy.

Authors:  A Alkarain; R Jordan; J Slingerland
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

3.  Cytoplasmic expression of p27(kip1) is associated with a favourable prognosis in colorectal cancer patients.

Authors:  Nicholas F S Watson; Lindy G Durrant; John H Scholefield; Zahra Madjd; Duncan Scrimgeour; Ian Spendlove; Ian O Ellis; Poulam M Patel
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

4.  A shift from nuclear to cytoplasmic breast cancer metastasis suppressor 1 expression is associated with highly proliferative estrogen receptor-negative breast cancers.

Authors:  Natalya Frolova; Mick D Edmonds; Thomas M Bodenstine; Robert Seitz; Martin R Johnson; Rui Feng; Danny R Welch; Andra R Frost
Journal:  Tumour Biol       Date:  2009-07-16

5.  Prognostic factors in prostate cancer.

Authors:  A Buhmeida; S Pyrhönen; M Laato; Y Collan
Journal:  Diagn Pathol       Date:  2006-04-03       Impact factor: 2.644

Review 6.  Measuring proliferation in breast cancer: practicalities and applications.

Authors:  Mark J Beresford; George D Wilson; Andreas Makris
Journal:  Breast Cancer Res       Date:  2006       Impact factor: 6.466

7.  Lymph node status as a guide to selection of available prognostic markers in breast cancer: the clinical practice of the future?

Authors:  A Elzagheid; T Kuopio; S Pyrhönen; Y Collan
Journal:  Diagn Pathol       Date:  2006-11-08       Impact factor: 2.644

Review 8.  The cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancer.

Authors:  R Chiarle; M Pagano; G Inghirami
Journal:  Breast Cancer Res       Date:  2000-12-20       Impact factor: 6.466

Review 9.  Deregulation of p27 by oncogenic signaling and its prognostic significance in breast cancer.

Authors:  Angel Alkarain; Joyce Slingerland
Journal:  Breast Cancer Res       Date:  2003-10-21       Impact factor: 6.466

Review 10.  p27(Kip1) as a prognostic factor in breast cancer: a systematic review and meta-analysis.

Authors:  Xiaoxiang Guan; Yucai Wang; Ruilian Xie; Longbang Chen; Jianling Bai; Jia Lu; Macus Tien Kuo
Journal:  J Cell Mol Med       Date:  2010-02-27       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.